Published in J Thyroid Res on June 19, 2011
Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes. Stem Cell Reports (2014) 1.12
Thyroid hormones and cardiovascular disease. Nat Rev Cardiol (2016) 0.93
Mitochondria as key targets of cardioprotection in cardiac ischemic disease: role of thyroid hormone triiodothyronine. Int J Mol Sci (2015) 0.86
Cell-type-dependent thyroid hormone effects on glioma tumor cell lines. J Thyroid Res (2011) 0.84
Cardioprotection and thyroid hormones. Heart Fail Rev (2016) 0.78
Early and short-term triiodothyronine supplementation prevents adverse post-ischemic cardiac remodeling: role of transforming growth factor-β1 and anti-fibrotic miRNA signaling. Mol Med (2015) 0.77
microRNA and thyroid hormone signaling in cardiac and skeletal muscle. Cell Biosci (2017) 0.75
Transient regenerative potential of the neonatal mouse heart. Science (2011) 9.02
Thyroid hormone and the cardiovascular system. N Engl J Med (2001) 5.56
Thyroid disease and the heart. Circulation (2007) 4.41
Molecular mechanisms of myocardial remodeling. Physiol Rev (1999) 4.27
The clinical significance of subclinical thyroid dysfunction. Endocr Rev (2007) 3.80
Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation (2003) 2.95
Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction. J Am Coll Cardiol (2009) 2.82
Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail Rev (2007) 2.67
Thyroid hormone action in the heart. Endocr Rev (2005) 2.57
Molecular regulation of cardiac hypertrophy. Int J Biochem Cell Biol (2008) 1.95
Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med (1995) 1.95
Regeneration in the metazoans: why does it happen? Bioessays (2000) 1.84
Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev (1982) 1.81
Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann N Y Acad Sci (2010) 1.74
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative study. Circulation (2009) 1.70
Safety and hemodynamic effects of intravenous triiodothyronine in advanced congestive heart failure. Am J Cardiol (1998) 1.70
Thyroid hormone activation in human vascular smooth muscle cells: expression of type II iodothyronine deiodinase. Circ Res (2001) 1.67
Sick euthyroid syndrome in patients with moderate-to-severe chronic heart failure. Eur Heart J (1996) 1.56
Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy. Am J Med (1996) 1.53
Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab (2000) 1.49
The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab (2010) 1.49
Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci U S A (1992) 1.49
Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med (2007) 1.40
Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart Circ Physiol (2001) 1.37
The Xenopus tadpole: a new model for regeneration research. Cell Mol Life Sci (2008) 1.29
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2008) 1.26
Thyroid replacement therapy and heart failure. Circulation (2010) 1.24
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem J (2005) 1.21
Regeneration: The origin of cancer or a possible cure? Semin Cell Dev Biol (2009) 1.14
Short term triiodo-L-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in rats. J Mol Cell Cardiol (2007) 1.11
Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Natl Acad Sci U S A (2006) 1.08
A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends Endocrinol Metab (2006) 1.08
Thyroid hormone and cardiovascular disease. Am Heart J (1998) 1.06
Altered thyroid hormone metabolism in advanced heart failure. J Am Coll Cardiol (1990) 1.05
Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat? N Engl J Med (1995) 1.03
A role of unliganded thyroid hormone receptor in postembryonic development in Xenopus laevis. Mech Dev (2007) 1.02
Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state. Thyroid (2002) 1.01
Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure. Circ Heart Fail (2009) 1.01
Cardiac effects of 3,5-diiodothyropropionic acid, a thyroid hormone analog with inotropic selectivity. J Pharmacol Exp Ther (1992) 1.01
Inducing cellular dedifferentiation: a potential method for enhancing endogenous regeneration in mammals. Semin Cell Dev Biol (2002) 1.00
Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med (2002) 0.98
Thyroid hormone changes cardiomyocyte shape and geometry via ERK signaling pathway: potential therapeutic implications in reversing cardiac remodeling? Mol Cell Biochem (2006) 0.96
Cardiovascular hemodynamics and exercise tolerance in thyroid disease. Thyroid (2002) 0.95
Triiodothyronine promotes cardiac differentiation and maturation of embryonic stem cells via the classical genomic pathway. Mol Endocrinol (2010) 0.95
Hyperthyroidism and cardiovascular morbidity and mortality. Thyroid (2002) 0.95
Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats. Basic Res Cardiol (2008) 0.94
Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy. Endocrinology (2007) 0.94
Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism. Horm Metab Res (2010) 0.94
Long-term thyroxine administration protects the heart in a pattern similar to ischemic preconditioning. Thyroid (2002) 0.93
The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence. Heart Fail Rev (2008) 0.93
Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2005) 0.92
Thyroid hormone receptor alpha 1: a switch to cardiac cell "metamorphosis"? J Physiol Pharmacol (2008) 0.91
Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysis. Circulation (2010) 0.91
Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. Ann N Y Acad Sci (2006) 0.91
Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats. Eur J Cardiothorac Surg (2007) 0.90
Thyroid hormone induces cardiac myocyte hypertrophy in a thyroid hormone receptor alpha1-specific manner that requires TAK1 and p38 mitogen-activated protein kinase. Mol Endocrinol (2005) 0.90
Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med (2005) 0.90
Prospective echocardiographic evaluation of patients with endogenous subclinical hyperthyroidism and after restoring euthyroidism. Clin Endocrinol (Oxf) (2011) 0.89
The amphioxus genome enlightens the evolution of the thyroid hormone signaling pathway. Dev Genes Evol (2008) 0.89
Functional and metabolic adaptation of the heart to prolonged thyroid hormone treatment. Am J Physiol Heart Circ Physiol (2002) 0.88
Thyroxine-induced cardiac hypertrophy: influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling. Am J Physiol Regul Integr Comp Physiol (2003) 0.88
L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect. Clin Pharmacol Ther (1984) 0.87
Pilot studies on the use of 3,5-diiodothyropropionic acid, a thyroid hormone analog, in the treatment of congestive heart failure. Cardiology (2002) 0.87
Do unliganded thyroid hormone receptors have physiological functions? J Mol Endocrinol (2003) 0.86
DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth. Am J Physiol Heart Circ Physiol (2002) 0.86
Usefulness of L-thyroxine to improve cardiac and exercise performance in idiopathic dilated cardiomyopathy. Am J Cardiol (1994) 0.86
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats. J Cell Mol Med (2011) 0.85
Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol (2009) 0.85
Thyroxine pretreatment increases basal myocardial heat-shock protein 27 expression and accelerates translocation and phosphorylation of this protein upon ischaemia. Eur J Pharmacol (2003) 0.84
Thyroid hormone receptors alpha1 and beta1 are downregulated in the post-infarcted rat heart: consequences on the response to ischaemia-reperfusion. Basic Res Cardiol (2005) 0.84
New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider? Heart Fail Rev (2011) 0.84
3,5,3'-Triiodothyronine deprivation affects phenotype and intracellular [Ca2+]i of human cardiomyocytes in culture. Cardiovasc Res (2001) 0.83
The role of redox signaling in cardiac hypertrophy induced by experimental hyperthyroidism. J Mol Endocrinol (2008) 0.83
Thyroxin regulates BDNF expression to promote survival of injured neurons. Mol Cell Neurosci (2009) 0.83
Triiodothyronine improves left ventricular function without oxygen wasting effects after global hypothermic ischemia. J Thorac Cardiovasc Surg (1995) 0.83
Hyperthyroid hearts display a phenotype of cardioprotection against ischemic stress: a possible involvement of heat shock protein 70. Horm Metab Res (2006) 0.82
Invited commentary: Cardiovascular mortality in subclinical hyperthyroidism: an ongoing dilemma. Eur J Endocrinol (2010) 0.81
Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy. Eur J Heart Fail (2005) 0.80
Usefulness of left ventricular diastolic dysfunction as a predictor of one-year rehospitalization in survivors of acute myocardial infarction. Am J Cardiol (2008) 0.80
Thyroid hormone at supra-physiological dose optimizes cardiac geometry and improves cardiac function in rats with old myocardial infarction. J Physiol Pharmacol (2009) 0.80
Ineffective cardiorespiratory function in hyperthyroidism. J Clin Endocrinol Metab (1998) 0.80
Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction. Basic Res Cardiol (2007) 0.80
Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling. Vascul Pharmacol (2009) 0.79
Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction. Mol Cell Biochem (2010) 0.78
Impaired Ca2+ handling and contraction in cardiomyocytes from mice with a dominant negative thyroid hormone receptor alpha1. J Mol Cell Cardiol (2005) 0.78
Effects of tetraiodothyronine and triiodothyronine on hamster cheek pouch microcirculation. Am J Physiol Heart Circ Physiol (2004) 0.78
Intravenous thyroid hormone supplementation in heart failure with cardiogenic shock. J Card Fail (1999) 0.77
Abnormal cardiac contractility in long-term exogenous subclinical hyperthyroid patients as demonstrated by two-dimensional echocardiography speckle tracking imaging. Eur J Endocrinol (2010) 0.76
Low serum triiodothyronine in acute myocardial infarction indicates major heart injury. Kardiol Pol (2004) 0.76
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
The differential impact of volatile and intravenous anaesthetics on stress response in the swine. Hormones (Athens) (2010) 1.56
Phenylephrine postconditioning increases myocardial injury: are alpha-1 sympathomimetic agonist cardioprotective? Ann Card Anaesth (2014) 1.39
Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab (2008) 1.26
Thyroid replacement therapy and heart failure. Circulation (2010) 1.24
The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab (2002) 1.13
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol (2011) 1.11
Age- and disease-related variations in B-type natriuretic peptide response after pediatric cardiac surgery. J Thorac Cardiovasc Surg (2013) 1.07
Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study. J Am Coll Cardiol (2005) 1.06
Thyroid hormone and coronary artery disease: from clinical correlations to prognostic implications. Clin Cardiol (2009) 0.97
Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. Endocrinology (2014) 0.96
Low triiodothyronine (T3) state: a predictor of outcome in respiratory failure? Results of a clinical pilot study. Eur J Endocrinol (2004) 0.96
Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab (2011) 0.95
Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: a strong association? Eur J Endocrinol (2011) 0.95
Stress/Rest Myocardial Perfusion Abnormalities by Gated SPECT: Still the Best Predictor of Cardiac Events in Stable Ischemic Heart Disease. J Nucl Med (2009) 0.92
Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med (2005) 0.90
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. J Card Fail (2009) 0.90
Neuroprotective actions of thyroid hormones and low-T3 syndrome as a biomarker in acute cerebrovascular disorders. Expert Rev Neurother (2015) 0.87
High glucose protects embryonic cardiac cells against simulated ischemia. Mol Cell Biochem (2006) 0.86
Persistence of mortality risk in patients with acute cardiac diseases and mild thyroid dysfunction. Am J Med Sci (2012) 0.86
In vivo and in vitro effects of cadmium on adult rat brain total antioxidant status, acetylcholinesterase, (Na+, K+)-ATPase and Mg2+-ATPase activities: protection by L-cysteine. Basic Clin Pharmacol Toxicol (2004) 0.86
Thyroid hormone and tissue repair: new tricks for an old hormone? J Thyroid Res (2013) 0.85
The obesity paradox and myocardial infarct size. J Cardiovasc Med (Hagerstown) (2007) 0.85
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats. J Cell Mol Med (2011) 0.85
Early activation of an altered thyroid hormone profile in asymptomatic or mildly symptomatic idiopathic left ventricular dysfunction. J Card Fail (2006) 0.84
Dose-dependent effects of sildenafil on post-ischaemic left ventricular function in the rat isolated heart. J Pharm Pharmacol (2010) 0.84
Acute myocardial infarction and thyroid function: new pathophysiological and therapeutic perspectives. Ann Med (2011) 0.84
Cell-type-dependent thyroid hormone effects on glioma tumor cell lines. J Thyroid Res (2011) 0.84
Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice. Mol Cell Biochem (2013) 0.84
Comparative effects of acute vs. chronic oral amiodarone treatment during acute myocardial infarction in rats. Europace (2007) 0.83
Low triiodothyronine and exercise capacity in heart failure. Int J Cardiol (2010) 0.82
Proangiogenic effect of TSH in human microvascular endothelial cells through its membrane receptor. J Clin Endocrinol Metab (2012) 0.82
Galectin-3 detection on large-needle aspiration biopsy improves preoperative selection of thyroid nodules: a prospective cohort study. Ann Med (2010) 0.82
Dose-dependent effects of thyroid hormone on post-ischemic cardiac performance: potential involvement of Akt and ERK signalings. Mol Cell Biochem (2011) 0.82
Thyroid hormones alterations during acute liver failure: possible underlying mechanisms and consequences. Endocrine (2009) 0.82
Changes in acetylcholinesterase, Na+,K+-ATPase, and Mg2+-ATPase activities in the frontal cortex and the hippocampus of hyper- and hypothyroid adult rats. Metabolism (2007) 0.81
Review and status report of pediatric left ventricular systolic strain and strain rate nomograms. Heart Fail Rev (2015) 0.80
Changes in thyroid hormone receptors after permanent cerebral ischemia in male rats. J Mol Neurosci (2014) 0.80
From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules. Biomed Pharmacother (2004) 0.80
Presence of a functional TSH receptor on human erythrocytes. Biomed Pharmacother (2007) 0.80
[Thyroid hormones and their action on the myocardium]. Bull Acad Natl Med (2009) 0.80
TSH induces co-localization of TSH receptor and Na/K-ATPase in human erythrocytes. Cell Biochem Funct (2009) 0.79
Functional effects of local thyroid hormone administration after sciatic nerve injury in rats. Microsurgery (2009) 0.79
Effects of acute and chronic cadmium administration on the vascular reactivity of rat aorta. Biometals (2006) 0.79
Mepivacaine alters vascular responsiveness to vasoconstrictors in aortic rings from normal and aortic-banded rats. Pharmacol Toxicol (2003) 0.79
Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: a response associated with up-regulation of Akt/mTOR and AMPK activation. Metabolism (2013) 0.79
Prognostic role of BNP in children undergoing surgery for congenital heart disease: analysis of prediction models incorporating standard risk factors. Clin Chem Lab Med (2015) 0.78
Multicentre comparison of free thyroid hormones immunoassays: the Immunocheck study. Clin Chem Lab Med (2011) 0.78
Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure. J Card Fail (2008) 0.78
Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction. Mol Cell Biochem (2010) 0.78
Itraconazole inhibits HMEC-1 angiogenesis. Biomed Pharmacother (2011) 0.78
Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats. Eur J Pharmacol (2007) 0.78
Thyroid hormone deiodinases D1, D2, and D3 are expressed in human endothelial dermal microvascular line: effects of thyroid hormones. Mol Cell Biochem (2014) 0.78
Amiodarone inhibits the 3,5,3'-triiodothyronine-dependent increase of sodium/potassium adenosine triphosphatase activity and concentration in human atrial myocardial tissue. Thyroid (2004) 0.78
Echocardiographic definition of restrictive patent foramen ovale (PFO). Heart (2013) 0.78
Prevalence of thyroid dysfunction and effect of contrast medium on thyroid metabolism in cardiac patients undergoing coronary angiography. Acta Radiol (2012) 0.77
Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocrine (2007) 0.77
Short-term ventricular restraint attenuates post-infarction remodeling in rats. Int J Cardiol (2011) 0.77
Changes in antioxidant status, protein concentration, acetylcholinesterase, (Na+,K+)-, and Mg2+ -ATPase activities in the brain of hyper- and hypothyroid adult rats. Metab Brain Dis (2005) 0.77
Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor. Cell Biochem Funct (2007) 0.76
Thyroid hormone and heart failure: from myocardial protection to systemic regulation. Expert Rev Cardiovasc Ther (2014) 0.76
Does large needle aspiration biopsy add pain to the thyroid nodule evaluation? PLoS One (2013) 0.76
Is the vascular system a main target for thyroid hormones? From molecular and biochemical findings to clinical perspectives. Curr Vasc Pharmacol (2005) 0.76
A glass of wine: how good is good? The resveratrol lesson*. Crit Care Med (2012) 0.76
Cathepsin K--a classical bone biomarker in cardiovascular disease: the heart is not alone anymore. Atherosclerosis (2013) 0.76
Thyroid hormone signalling is altered in response to physical training in patients with end-stage heart failure and mechanical assist devices: potential physiological consequences? Interact Cardiovasc Thorac Surg (2013) 0.76
Thyroid hormone at physiological doses restores depressed contractile reserve and impaired calcium handling of cardiac myocytes from chronically unloaded hearts. Acta Physiol (Oxf) (2007) 0.76
Thyroid hormone receptor and IGF1/IGFR systems: possible relations in the human heart. Biomed Pharmacother (2007) 0.75
Comment: worsening heart failure in the setting of dronedarone initiation. Ann Pharmacother (2011) 0.75
Relation of triiodothyronine to subclinical myocardial injury in patients with chest pain. Am J Cardiol (2013) 0.75
Morphine administration at reperfusion fails to improve postischaemic cardiac function but limits myocardial injury probably via heat-shock protein 27 phosphorylation. Eur J Anaesthesiol (2009) 0.75
Thyroid (dys)function in heart failure: is it a potential target for medical treatment? Vasc Health Risk Manag (2005) 0.75
Thyroid function and cardiac surgery: what should we measure, and when? Ann Thorac Surg (2010) 0.75
Triiodothyronine (T3) effects on cardiovascular system in patients with heart failure. Recent Pat Cardiovasc Drug Discov (2008) 0.75
A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk. Ther Clin Risk Manag (2011) 0.75
Loss of cardioprotection induced by ischemic preconditioning after an initial ischemic period in isolated rat hearts. Exp Clin Cardiol (2003) 0.75
Nonthyroidal illness syndrome in off-pump coronary artery bypass grafting. Ann Thorac Surg (2003) 0.75
Challenges of LADA Diagnosis and Treatment: Lessons From 2 Case Reports. Am J Ther (2016) 0.75
Strengths, Limitations, and Geographical Discrepancies in the Eligibility Criteria for Sport Participation in Young Patients With Congenital Heart Disease. Clin J Sport Med (2017) 0.75
Acute infusion of recombinant human thyrotropin in Langendorff-rat hearts: role of a thyrotropin receptor. Int J Cardiol (2009) 0.75
Thyroid and brain natriuretic Peptide response in children undergoing cardiac surgery for congenital heart disease- age-related variations and prognostic value. Circ J (2012) 0.75
Perioperative changes in atrial natriuretic peptide plasma levels associated with mitral and aortic valve replacement. J Cardiothorac Vasc Anesth (2004) 0.75
[Type 1 diabetes impairs compensatory response after myocardial infarction; role of tissue hypothyroidism and effects of thyroid hormone administration]. Bull Acad Natl Med (2011) 0.75
Acute effect of TSH on oxygenation state and volume of erythrocytes from subjects thyroidectomized for differentiated thyroid carcinoma. Biomed Pharmacother (2011) 0.75
Impact of thyroid hormone administration on fluid requirements and hepatic injury markers in hemorrhagic shock due to liver trauma. J Invest Surg (2013) 0.75
Vitamin K Deficiency in Chronic Kidney Disease: Evidence Is Building Up. Am J Nephrol (2016) 0.75
[Thyroid function and heart failure: from the new clinical evidences to the potential therapeutical implications]. Recenti Prog Med (2005) 0.75
Effects of hyper- and hypothyroidism on acetylcholinesterase, (Na(+), K (+))- and Mg ( 2+ )-ATPase activities of adult rat hypothalamus and cerebellum. Metab Brain Dis (2006) 0.75
On the paradox insulin resistance/insulin hypersensitivity and obesity: two tales of the same history. Expert Rev Cardiovasc Ther (2014) 0.75